TransMedics has raised over $90 million in venture capital funding with investments from the following firms:
3i Group
Alta Partners
CB Health Ventures
Flagship Ventures
JP Morgan
Posco BioVentures
Sagamore Bioventures
Sherbrooke Capital
Tudor Investment Corporation
VantagePoint Venture Partners
TransMedics, Inc., Closes $25.5 Million in Series D FundingAndover, MA - April 13, 2007
TransMedics, Inc., an emerging medical technology company developing advanced solutions to address the unmet need for better, more effective organ transplants, announced today that it has closed a $25.5 million Series D private equity financing led by funds affiliated with and advised by Tudor Investments.
No comments:
Post a Comment